EE200300572A - Parasiitseente kindlakstegemine organismis ja nende töötlemine - Google Patents

Parasiitseente kindlakstegemine organismis ja nende töötlemine

Info

Publication number
EE200300572A
EE200300572A EEP200300572A EEP200300572A EE200300572A EE 200300572 A EE200300572 A EE 200300572A EE P200300572 A EEP200300572 A EE P200300572A EE P200300572 A EEP200300572 A EE P200300572A EE 200300572 A EE200300572 A EE 200300572A
Authority
EE
Estonia
Prior art keywords
identification
processing
parasitic fungi
fungi
parasitic
Prior art date
Application number
EEP200300572A
Other languages
English (en)
Inventor
Antonov Roumen
Original Assignee
Antonov Roumen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0106775A external-priority patent/FR2825024B1/fr
Priority claimed from FR0109203A external-priority patent/FR2827173B3/fr
Application filed by Antonov Roumen filed Critical Antonov Roumen
Publication of EE200300572A publication Critical patent/EE200300572A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
EEP200300572A 2001-05-23 2002-05-23 Parasiitseente kindlakstegemine organismis ja nende töötlemine EE200300572A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0106775A FR2825024B1 (fr) 2001-05-23 2001-05-23 Identification de champignons parasites de l'organisme, et leur traitement
FR0109203A FR2827173B3 (fr) 2001-07-11 2001-07-11 Identification de champignons parasites de l'organisme, et leur traitement
PCT/FR2002/001739 WO2002094287A2 (fr) 2001-05-23 2002-05-23 Identification de champignons parasites de l'organisme, et traitement des maladies liees

Publications (1)

Publication Number Publication Date
EE200300572A true EE200300572A (et) 2004-02-16

Family

ID=26213022

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300572A EE200300572A (et) 2001-05-23 2002-05-23 Parasiitseente kindlakstegemine organismis ja nende töötlemine

Country Status (18)

Country Link
US (1) US20040198633A1 (et)
EP (1) EP1389120B1 (et)
KR (1) KR20040018377A (et)
CN (1) CN1518451A (et)
BG (1) BG66299B1 (et)
BR (1) BR0209869A (et)
CA (1) CA2448045A1 (et)
CZ (1) CZ20033145A3 (et)
EE (1) EE200300572A (et)
HU (1) HUP0400035A2 (et)
IL (1) IL158967A0 (et)
NO (1) NO20035188D0 (et)
NZ (1) NZ529764A (et)
PL (1) PL367700A1 (et)
RU (1) RU2003136777A (et)
SK (1) SK14372003A3 (et)
WO (1) WO2002094287A2 (et)
ZA (1) ZA200309122B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
CN103044376A (zh) * 2012-12-15 2013-04-17 青岛农业大学 桑黄菌中吡喃酮的分离技术
CN116515641B (zh) * 2023-04-26 2023-09-29 吉林农业大学 一株珊瑚状猴头菌及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786781A (en) * 1954-11-04 1957-03-26 Olin Mathieson Process of recovering nystatin
US2908611A (en) * 1954-12-28 1959-10-13 Olin Mathieson Amphotericin b, its production, and its salts
US3714348A (en) * 1970-12-02 1973-01-30 Schmid Inc Julius Method for controlling absorption of cholesterol
US4025620A (en) * 1975-10-22 1977-05-24 Leo Pharmaceutical Products Ltd., A/S Treatment of canine otitis and composition therefor
US4491588A (en) * 1982-03-31 1985-01-01 University Of Tennessee Research Corporation Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics
GB9320744D0 (en) * 1992-11-04 1993-12-01 Zeneca Ltd Oxa and thiadiazole derivatives
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
EP0771205A2 (de) * 1994-06-28 1997-05-07 Dr. Zerle Gmbh Neue klinische anwendungen von polyen-makroliden
US5914239A (en) * 1995-11-15 1999-06-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses
WO2001014592A2 (en) * 1999-08-25 2001-03-01 Clarity Biosciences, Inc. Identifying organisms by detecting intronic nucleic acid or encoded proteins

Also Published As

Publication number Publication date
CA2448045A1 (fr) 2002-11-28
EP1389120B1 (fr) 2012-08-01
US20040198633A1 (en) 2004-10-07
WO2002094287A3 (fr) 2003-09-25
BR0209869A (pt) 2004-04-20
EP1389120A2 (fr) 2004-02-18
BG108375A (bg) 2005-01-31
BG66299B1 (bg) 2013-03-29
ZA200309122B (en) 2004-11-24
PL367700A1 (en) 2005-03-07
SK14372003A3 (sk) 2004-05-04
KR20040018377A (ko) 2004-03-03
CN1518451A (zh) 2004-08-04
NO20035188D0 (no) 2003-11-21
CZ20033145A3 (cs) 2004-10-13
IL158967A0 (en) 2004-05-12
RU2003136777A (ru) 2005-04-10
WO2002094287A2 (fr) 2002-11-28
NZ529764A (en) 2005-08-26
HUP0400035A2 (hu) 2004-04-28

Similar Documents

Publication Publication Date Title
DE60231796D1 (de) Kit und system zur immobilisierung von objekten im körper
FI20011140A (fi) Älytarra ja älytarraraina
NO20034805L (no) CRIPTO-blokkerende antistoff samt anvendelse derav
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE50209528D1 (de) Einzugs- und Pflückeinrichtung
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
FI20011370A (fi) Biotunnistusmenetelmä ja sitä hyödyntävä laite
DE60209144D1 (de) Viskoelastische ophthalmische zubereitungen enthaltend hyaluronsäure und chondroitinsulfat
EE200300572A (et) Parasiitseente kindlakstegemine organismis ja nende töötlemine
IT1315287B1 (it) Chiusura semplificata per oggetti di gioielleria e/o bigiotteria
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
DE60143772D1 (de) Walzverfahren und walzwerk
DE50210561D1 (de) Sitz- und/oder liegemöbel
DE60205008D1 (de) Kettelverfahren und -vorrichtung
DE60219418T8 (de) Silanylphenole und -naphthole
ITMI20011268A0 (it) Palle palloni e altri oggetti gonfiabili per uso ginnico o terapeutico
DE50214117D1 (de) Trenneinrichtung und Mähgerät oder Mähwerk
AU2002304492A1 (en) Identifying parasitic fungi of the organism, and treatment thereof
FR2827173B3 (fr) Identification de champignons parasites de l'organisme, et leur traitement
ITMI20010908A0 (it) Procedimento e dispositivo per la fabbricazione di contenitori chiusi
ITMI20011210A0 (it) Corticosteroidi-21-glicolati e 21-acilglicolati
DE50103140D1 (de) Zähler- und/oder Verteilervorrichtung
AU2002258548A1 (en) Identification of the ikappabns protein and its products